Diabetes Care, Vol 23, Issue 11 1672-1678, Copyright © 2000 by American Diabetes Association

ARTICLES

Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance

RM Voutilainen-Kaunisto, ME Terasvirta, MI Uusitupa and LK Niskanen
Department of Ophthalmology, Kuopio University Hospital, Finland.

OBJECTIVE: To investigate the evolution of visual acuity, age-related macular degeneration (AMD), and its relation to 10-year cardiovascular mortality and risk factors in patients with newly diagnosed type 2 diabetes and control subjects. RESEARCH DESIGN AND METHODS: A 10-year prospective study consisting of a representative group of 133 (70 men, 63 women) newly diagnosed type 2 diabetic patients diagnosed at health centers between 1979 and 1981 and 144 (62 men, 82 women) nondiabetic control subjects recruited from the population register was performed. The frequency of AMD was determined by grading of 45 degrees stereoscopic fundus photographs. The subjects were studied at baseline and after 5 and 10 years. RESULTS: By the 10-year follow-up, visual acuity had declined more markedly in the diabetic patients than in the control subjects. Although the frequency of AMD was nearly the same in both groups (11-19%), it decreased visual acuity earlier in the diabetic patients than in the control group. AMD at baseline predicted 10-year cardiovascular mortality independently of adjustment for other risk factors in the diabetic patients (odds ratio [95% CI] 4.7 [1.1-19.3], P = 0.033). CONCLUSIONS: Visual acuity deteriorated earlier in newly diagnosed type 2 diabetic patients than in the control group although the cross-sectional frequency of AMD was nearly the same in both groups. Interestingly, AMD was an independent risk factor for cardiovascular mortality in type 2 diabetic patients, but the background mechanism(s) behind this association is unknown.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. S. E. Jeganathan, J. J. Wang, and T. Y. Wong Ocular Associations of Diabetes Other Than Diabetic Retinopathy Diabetes Care, September 1, 2008; 31(9): 1905 - 1912. [Full Text] [PDF]

				N. Cheung, A. Shankar, R. Klein, A. R. Folsom, D. J. Couper, T. Y. Wong, and for the Atherosclerosis Risk in Communities (ARIC) Age-Related Macular Degeneration and Cancer Mortality in the Atherosclerosis Risk in Communities Study Arch Ophthalmol, September 1, 2007; 125(9): 1241 - 1247. [Abstract] [Full Text] [PDF]

				I. Kaur, A. Hussain, N. Hussain, T. Das, A. Pathangay, A. Mathai, A. Hussain, R. Nutheti, P. K. Nirmalan, and S. Chakrabarti Analysis of CFH, TLR4, and APOE Polymorphism in India Suggests the Tyr402His Variant of CFH to be a Global Marker for Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3729 - 3735. [Abstract] [Full Text] [PDF]

				S. Krishnaiah, T. Das, P. K. Nirmalan, R. Nutheti, B. R. Shamanna, G. N. Rao, and R. Thomas Risk Factors for Age-Related Macular Degeneration: Findings from the Andhra Pradesh Eye Disease Study in South India Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4442 - 4449. [Abstract] [Full Text] [PDF]

				G B Arden, R L Sidman, W Arap, and R O Schlingemann Spare the rod and spoil the eye Br. J. Ophthalmol., June 1, 2005; 89(6): 764 - 769. [Abstract] [Full Text] [PDF]